Puneet Singh

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Clinical Outcomes in Patients with Early Stage Node-Negative HER2-Positive Breast Cancer Receiving Upfront Surgery or Neoadjuvant Systemic Therapy”.

Clinical Outcomes in Patients with Early Stage Node-Negative HER2-Positive Breast Cancer Receiving Upfront Surgery or Neoadjuvant Systemic Therapy

Annals of Surgical Oncology(2024)10.1245/s10434-024-16087-x

N/A

0.359DataRank · unranked

4 citations

Taiwo Adesoye, Min Yi, Susie X. Sun, Mariana Chávez‐MacGregor, Puneet Singh +5 more

National trends in neoadjuvant systemic therapy utilization in patients with early-stage HER2-positive breast cancer from 2016–2021: The impact of the KATHERINE trial

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07750-2

N/A

0DataRank · unranked

5 citations

Christine C Rogers, Jan Irene Lloren, Sailaja Kamaraju, Lubna N. Chaudhary, Chiang‐Ching Huang +6 more

Correction: Impact of Pathologic Complete Response on Local-Regional Recurrence and Survival in Patients Undergoing Neoadjuvant Systemic Therapy and Breast-Conserving Surgery

Annals of Surgical Oncology(2025)10.1245/s10434-025-18401-7

N/A

0DataRank · unranked

0 citations

Alexa Glencer, Min Yi, Emma Wingate, Hannah F. Wingate, Naid Allassan +6 more